2H-OXACYCLOTETRADECINO(4,3-D)OXAZOLE-2,6,8,14(1H,7H,9H)-TETRONE, 4-ETHYLOCTAHYDRO-1-(4-HYDROXYBUTYL)-11-METHOXY-3A,7,9,11,13,15-HEXAMETHYL-10-((3,4,6-TRIDEOXY-3-(DIMETHYLAMINO)-.BETA.-D-XYLO-HEXOPYRANOSYL)OXY)-, (3AS,4R,7R,9R,10R,11R,13R,15R,15AR)-
UNII LXK6TC4HWU
Substance Identification & Data
This profile provides standardized clinical and technical data for 2h-oxacyclotetradecino(4,3-d)oxazole-2,6,8,14(1h,7h,9h)-tetrone, 4-ethyloctahydro-1-(4-hydroxybutyl)-11-methoxy-3a,7,9,11,13,15-hexamethyl-10-((3,4,6-trideoxy-3-(dimethylamino)-.beta.-d-xylo-hexopyranosyl)oxy)-, (3as,4r,7r,9r,10r,11r,13r,15r,15ar)-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) LXK6TC4HWU.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 223494-59-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C35H60N2O11 GFUDYZUOIIIPBM-UGWDLRSTSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 2h-oxacyclotetradecino(4,3-d)oxazole-2,6,8,14(1h,7h,9h)-tetrone, 4-ethyloctahydro-1-(4-hydroxybutyl)-11-methoxy-3a,7,9,11,13,15-hexamethyl-10-((3,4,6-trideoxy-3-(dimethylamino)-.beta.-d-xylo-hexopyranosyl)oxy)-, (3as,4r,7r,9r,10r,11r,13r,15r,15ar)-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.